Literature DB >> 9815149

Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma.

M Aikawa1, E Rabkin, S J Voglic, H Shing, R Nagai, F J Schoen, P Libby.   

Abstract

Smooth muscle cells (SMCs) in the atherosclerotic intima characteristically differ from those in the arterial media, for example, by reduced expression of SMC differentiation/maturation markers such as smooth muscle myosin heavy chain isoforms (SM1 and SM2). This study tested the hypothesis that lipid lowering promotes maturation of intimal SMCs in 33 rabbits subjected to balloon injury and cholesterol feeding (0.3%) for 4 months (Baseline group, n=15); some of which then were switched to a low-cholesterol diet for 8 months (Low group at 8 months, n=3) or 16 months (Low group at 16 months, n=10). The remaining rabbits continued to consume a high-cholesterol diet for 16 months (High group, n=5). We monitored SMC phenotype by expression of immunoreactive alpha-smooth muscle actin, SM1, and SM2. alpha-Actin is an early marker, and SM1 and SM2 are late markers for SMC differentiation/maturation. Only fully differentiated or mature SMCs express SM2. Data are reported as the percentage of the alpha-actin-positive intimal area occupied by smooth muscle myosin-positive SMCs determined by color image analysis of immunostained sections. Levels of SM1 and SM2, highly expressed by SMCs in the normal aortic media (n=5) decreased in the aortic intima of the Baseline and High groups, indicating a less mature phenotype. In contrast, SM1 and SM2 increased in the Low (16 months) group, indicating that intimal SMCs exhibit a more mature phenotype after lipid lowering. Electron microscopy also showed the presence of mature intimal SMCs with abundant myofilaments. Furthermore, lipid lowering reduced levels of platelet-derived growth factor-B in the arterial intima, a factor known to suppress smooth muscle myosin expression. These data demonstrate that lipid lowering favors accumulation of mature SMCs in the atherosclerotic intima in association with reduced levels of platelet-derived growth factor-B expression. Intimal SMCs in the Low group also displayed reduced expression of matrix metalloproteinases-3 and -9 compared with the Baseline and High groups. These findings shed new light on the effects of lipid lowering at the level of the vascular wall, which may influence the biology of the atheroma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815149     DOI: 10.1161/01.res.83.10.1015

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  25 in total

1.  Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury.

Authors:  C P Regan; P J Adam; C S Madsen; G K Owens
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  New insights into atherosclerotic plaque rupture.

Authors:  D M Braganza; M R Bennett
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

Review 3.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 4.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

5.  Hypertensive vascular remodeling was inhibited by Xuezhikang through the regulation of Fibulin-3 and MMPs in spontaneously hypertensive rats.

Authors:  Zhong-Wei Lin; Zhuo Wang; Gui-Ping Zhu; Bo-Wei Li; Wen-Lin Xie; Ding-Cheng Xiang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

6.  Matrix metalloproteinases and cardiovascular diseases.

Authors:  A Papazafiropoulou; N Tentolouris
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

Review 7.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

8.  Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability.

Authors:  Shaw-Yung Shai; Sergiy Sukhanov; Yusuke Higashi; Charlotte Vaughn; James Kelly; Patrice Delafontaine
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07-29       Impact factor: 8.311

9.  Fibronectin-based isolation of valve interstitial cell subpopulations: relevance to valve disease.

Authors:  Elizabeth H Stephens; Thanh N Huynh; Jennifer D Cieluch; K Jane Grande-Allen
Journal:  J Biomed Mater Res A       Date:  2010-01       Impact factor: 4.396

10.  Brg1 governs distinct pathways to direct multiple aspects of mammalian neural crest cell development.

Authors:  Wei Li; Yiqin Xiong; Ching Shang; Karen Y Twu; Calvin T Hang; Jin Yang; Pei Han; Chieh-Yu Lin; Chien-Jung Lin; Feng-Chiao Tsai; Kryn Stankunas; Tobias Meyer; Daniel Bernstein; Minggui Pan; Ching-Pin Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.